Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001155
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
1999-11-03
Brief Title:
Treatment of Wegeners Granulomatosis With Cyclophosphamide
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Treatment of Wegeners Granulomatosis With Cyclophosphamide
Status:
COMPLETED
Status Verified Date:
2002-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this protocol is to continue to treat patients with Wegeners granulomatosis who have already entered the study and to treat new patients The investigators will attempt to correlate the clinical response with specific immunosuppressive effects of drug administration The investigators are accumulating data on the optimal duration and side effects of therapy
Detailed Description:
The purpose of the protocol is to continue to treat patients with Wegeners granulomatosis who have already entered the study and to treat new patients The investigators will attempt to correlate the clinical response with specific immunosuppressive effects of drug administration The investigators are accumulating data on the optimal duration and side effects of therapy
Age Range greater than 1 year
Age Range greater than 1 year
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 76-I-0042 | None | None | None |